Completed NA INTERVENTIONAL 2-arm NCT05205876

Safety and Feasibility Study of the Eddii Mobile Application

A Safety and Feasibility Study of the Eddii Mobile Application for Glucose Monitoring in Pediatric Patients With Type I Diabetes

Sponsor: Eddii, Inc.

Conditions Type-1 Diabetes

Interventions Eddii mobile application

Updated 4 times since 2022 Last updated: Oct 2, 2022 Started: Jan 2, 2021 Primary completion: Jul 31, 2022 Completion: Aug 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Type-1 Diabetes and is currently completed. Eddii, Inc. leads this study, which shows 4 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Nov 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Feb 2022 — Nov 2022 [monthly]

Recruiting NA

First recorded

Jan 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eddii, Inc.

Data source: Eddii, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States